MK-0873

CAS No. 500355-52-2

MK-0873( —— )

Catalog No. M34654 CAS No. 500355-52-2

MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 200 In Stock
10MG 302 In Stock
25MG 489 In Stock
50MG 695 In Stock
100MG 977 In Stock
200MG 1321 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MK-0873
  • Note
    Research use only, not for human use.
  • Brief Description
    MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
  • Description
    MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    500355-52-2
  • Formula Weight
    422.44
  • Molecular Formula
    C25H18N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC1CC1)(=O)C2=CN(C=3C(C2=O)=CC=CN3)C4=CC(C#CC5=CN(=O)=CC=C5)=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Verofylline

    Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.

  • PF-8380

    Potent autotaxin inhibitor (IC50?= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood).

  • Dovramilast

    Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.